0000950142-14-000380.txt : 20140213
0000950142-14-000380.hdr.sgml : 20140213
20140213161539
ACCESSION NUMBER: 0000950142-14-000380
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20131231
FILED AS OF DATE: 20140213
DATE AS OF CHANGE: 20140213
EFFECTIVENESS DATE: 20140213
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aisling Capital LLC
CENTRAL INDEX KEY: 0001571076
IRS NUMBER: 010849048
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15878
FILM NUMBER: 14606289
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVENUE, 30TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
BUSINESS PHONE: 212-651-6372
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVENUE, 30TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001571076
XXXXXXXX
12-31-2013
12-31-2013
false
Aisling Capital LLC
888 Seventh Avenue, 30th Floor
New York
NY
10106
13F HOLDINGS REPORT
028-15878
N
Lloyd Appel
Chief Financial Officer
212-651-6372
/s/ Lloyd Appel
New York
NY
02-13-2014
0
6
163600
INFORMATION TABLE
2
infotable.xml
Durata Therapeutics, Inc.
Common Stock
26658A107
40000
3130824
SH
SOLE
3130824
0
0
Quintiles Transnational Corp.
Common Stock
74876Y101
84500
1823575
SH
SOLE
1823575
0
0
Intercept Pharmaceuticals
Common Stock
45845P108
9400
137519
SH
SOLE
137519
0
0
Chimerix, Inc.
Common Stock
16934W106
18500
1222943
SH
SOLE
1222943
0
0
MEI Pharma, Inc.
Common Stock
57232I303
6200
770000
SH
SOLE
770000
0
0
Sorrento Therapeutics, Inc
Common Stock
83587F202
5000
620700
SH
SOLE
620700
0
0